"Emtricitabine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A deoxycytidine analog and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B viruses. It is used to treat HIV INFECTIONS.
| Descriptor ID |
D000068679
|
| MeSH Number(s) |
D03.383.742.680.245.500.600 D13.570.230.329.525 D13.570.685.245.500.600
|
| Concept/Terms |
Emtricitabine- Emtricitabine
- Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine
- Beta L 2',3' dideoxy 5 fluoro 3' thiacytidine
|
Below are MeSH descriptors whose meaning is more general than "Emtricitabine".
Below are MeSH descriptors whose meaning is more specific than "Emtricitabine".
This graph shows the total number of publications written about "Emtricitabine" by people in this website by year, and whether "Emtricitabine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 2 | 2 |
| 2018 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Emtricitabine" by people in Profiles.
-
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. Antimicrob Agents Chemother. 2023 04 18; 67(4):e0005323.
-
MyTPill: study protocol for a cross-over randomised controlled trial comparing novel strategies to monitor antiretroviral adherence among HIV+ prescription opioid users. BMJ Open. 2023 01 10; 13(1):e062805.
-
Tenofovir disoproxil fumarate and coronavirus disease 2019 outcomes in men with HIV. AIDS. 2022 10 01; 36(12):1689-1696.
-
Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis. J Control Release. 2018 09 28; 286:315-325.
-
Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-na?ve HIV-infected individuals. J Neurovirol. 2017 10; 23(5):704-712.
-
Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models. AIDS. 2013 Nov 28; 27(18):2943-51.
-
Patient-reported symptoms on the antiretroviral regimen efavirenz/emtricitabine/tenofovir. AIDS Patient Care STDS. 2012 Jun; 26(6):312-9.
-
Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients. Int J STD AIDS. 2012 May; 23(5):351-5.
-
Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis. AIDS. 2007 Sep 12; 21(14):1899-907.
-
Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Aug 05; 822(1-2):201-8.